Proteomics of vitreous humor of patients with exudative age-related macular degeneration

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Koss, Michael Janusz ^a,b,c   Hoffmann, Janosch ^d   Nguyen, Nauke ^a   Pfister, Marcel ^b   Mischak, Harald ^d,e   Mullen, William ^e   Husi, Holger ^e   Rejdak, Robert ^f   Koch, Frank ^a   Jankowski, Joachim ^g   Krueger, Katharina ^g   Bertelmann, Thomas ^h   Klein, Julie ^d   Schanstra, Joost P ^d,i,j   Siwy, Justyna ^d,g  

^a GOETHE UNIVERSITY   (Germany)

^b DOHENY EYE INSTITUTE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Mosaiques Diagnostics   (Germany)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f Lublin University   (Poland)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁱ INSERM   (France)

^j UNIVERSITÉ PAUL SABATIER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; FIBRINOGEN; FIBRINOGEN A ALPHA CHAIN; PROSTAGLANDIN D SYNTHASE; UNCLASSIFIED DRUG; BEVACIZUMAB; BIOLOGICAL MARKER; FIBRINOGEN ALPHAC; ISOMERASE; LIPOCALIN; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT; PROSTAGLANDIN R2 D-ISOMERASE; STEROID;

ACUTE PHASE RESPONSE; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CAPILLARY ELECTROPHORESIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PATHOPHYSIOLOGY; RETINA MACULA AGE RELATED DEGENERATION; SYSTEMS BIOLOGY; UPREGULATION; VERY ELDERLY; VITREOUS BODY; VITREOUS FLOATERS; WESTERN BLOTTING; CASE CONTROL STUDY; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PROTEOMICS; VITRECTOMY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; GENE EXPRESSION REGULATION; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEOMICS; STEROIDS; VITRECTOMY; VITREOUS BODY; WET MACULAR DEGENERATION;

EID: 84901316224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096895     Document Type: Article

References (42)

1. Evans JR (2001) Risk factors for age-related macular degeneration. Progress in retinal and eye research 20: 227-253.
2. Stefansson E (2009) Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 247: 147-163.
3. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, et al. (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Archives of ophthalmology 114: 66-71. (Pubitemid 26026196)
4. Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, et al. (2009) Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 116: 2393-2399.
5. Grossniklaus HE, Green WR (2004) Choroidal neovascularization. Am J Ophthalmol 137: 496-503. (Pubitemid 38328642)
6. Kim TW, Kang JW, Ahn J, Lee EK, Cho KC, et al. (2012) Proteomic analysis of the aqueous humor in age-related macular degeneration (AMD) patients. Journal of proteome research 11: 4034-4043.
7. Ecker SM, Hines JC, Pfahler SM, Glaser BM (2011) Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous. Molecular vision 17: 2856-2863.
8. Stefansson E, Loftsson T (2006) The Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmol Scand 84: 718-719. (Pubitemid 44688317)
9. Angi M, Kalirai H, Coupland SE, Damato BE, Semeraro F, et al. (2012) Proteomic analyses of the vitreous humour. Mediators of inflammation 2012: 148039.
10. Ecker SM, Pfahler SM, Hines JC, Lovelace AS, Glaser BM (2012) Sequential inoffice vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration. Molecular vision 18: 1658-1667.
11. Grus FH, Joachim SC, Pfeiffer N (2007) Proteomics in ocular fluids. Proteomics Clinical applications 1: 876-888.
12. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, et al. (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22: 42-48.
13. Pfister M, Koch FH, Cinatl J, Rothweiler F, Schubert R, et al. (2012) [Cytokine determination from vitreous samples in retinal vascular diseases.]. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
14. Walia S, Clermont AC, Gao BB, Aiello LP, Feener EP (2010) Vitreous proteomics and diabetic retinopathy. Seminars in ophthalmology 25: 289-294.
15. Yamane K, Minamoto A, Yamashita H, Takamura H, Miyamoto-Myoken Y, et al. (2003) Proteome analysis of human vitreous proteins. Molecular & cellular proteomics: MCP 2: 1177-1187.
16. Bennett KL, Funk M, Tschernutter M, Breitwieser FP, Planyavsky M, et al. (2011) Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ(R)-labelled specimens. Journal of proteomics 74: 151-166.
17. Chowdhury UR, Jea SY, Oh DJ, Rhee DJ, Fautsch MP (2011) Expression profile of the matricellular protein osteopontin in primary open-angle glaucoma and the normal human eye. Investigative ophthalmology & visual science 52: 6443-6451.
18. Cryan LM, O'Brien C (2008) Proteomics as a research tool in clinical and experimental ophthalmology. Proteomics Clinical applications 2: 762-775.
19. Zurbig P, Renfrow MB, Schiffer E, Novak J, Walden M, et al. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27: 2111-2125. (Pubitemid 43942113)
20. Mischak H, Vlahou A, Ioannidis JP (2013) Technical aspects and interlaboratory variability in native peptide profiling: the CE-MS experience. Clinical biochemistry 46: 432-443.
21. Mischak H, Julian BA, Novak J (2007) High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clinical applications 1: 792.
22. Koss MJ, Scholtz S, Haeussler-Sinangin Y, Singh P, Koch FH (2009) Combined Intravitreal Pharmacosurgery in Patients with Occult Choroidal Neovascularization Secondary to Wet Age-Related Macular Degeneration. Ophthalmologica 224: 72-78.
23. Mischak H, Schanstra JP (2011) CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clinical applications 5: 9-23.
24. Augustin AJ, Puls S, Offermann I (2007) Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Retina 27: 133-140.
25. Koch FH, Koss MJ (2011) Microincision vitrectomy procedure using Intrector technology. Archives of ophthalmology 129: 1599-1604.
26. Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141: 149-156.
27. Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, et al. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. The lancet oncology 7: 230-240. (Pubitemid 43286453)
28. Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, et al. (2004) Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid communications in mass spectrometry: RCM 18: 149-156. (Pubitemid 38160349)
29. Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, et al. (2009) Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. Journal of proteome research 8: 268-281.
30. Metzger J, Negm AA, Plentz RR, Weismuller TJ, Wedemeyer J, et al. (2013) Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Gut 62: 122-130.
31. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B (Methodological): 125-133.
32. Wohlrab W, Neubert RRH, Wohlraub J (2004) Hyaluronsaeure und Haut. Aachen: Shaker. 384 p.
33. Chowers I, Wong R, Dentchev T, Farkas RH, Iacovelli J, et al. (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Investigative ophthalmology & visual science 47: 2135-2140. (Pubitemid 46768298)
34. Wysokinski D, Danisz K, Blasiak J, Dorecka M, Romaniuk D, et al. (2013) An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration. Experimental eye research 1: 14-23.
35. Boehm N, Wolters D, Thiel U, Lossbrand U, Wiegel N, et al. (2012) New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study. Brain, behavior, and immunity 26: 96-102.
36. Klingel R, Fassbender C, Fischer I, Hattenbach L, Gumbel H, et al. (2002) Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology. Therapeutic apheresis: official journal of the International Society for Apheresis and the Japanese Society for Apheresis 6: 271-281.
37. Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, et al. (2010) RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 14: 276-286.
38. Garcia-Ramirez M, Canals F, Hernandez C, Colome N, Ferrer C, et al. (2007) Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 50: 1294-1303. (Pubitemid 46701542)
39. Kim SJ, Kim S, Park J, Lee HK, Park KS, et al. (2006) Differential expression of vitreous proteins in proliferative diabetic retinopathy. Current eye research 31: 231-240. (Pubitemid 43379193)
40. Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, et al. (2012) Identification of anti-retinal antibodies in patients with age-related macular degeneration. Experimental and molecular pathology 93: 193-199.
41. Morohoshi K, Patel N, Ohbayashi M, Chong V, Grossniklaus HE, et al. (2012) Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Experimental and molecular pathology 92: 64-73.
42. Kisic B, Miric D, Zoric L, Ilic A, Dragojevic I (2012) Antioxidant capacity of lenses with age-related cataract. Oxidative medicine and cellular longevity 2012: 467130.